Benjamin A.

Benjamin A. has a diverse work experience in the healthcare industry, starting in 2008. Benjamin has held various leadership roles and advisory positions in multiple companies. Currently, they serve as the Chief Medical Officer - Fractional at Digital Therapeutics Alliance and is also the Clinician Education Task Group Co-Chair. Benjamin has also worked as a Medical Advisor at Anicca Health, a Member of the Scientific Advisory Board at Big Health, and an Advisor at sersha.ai. In addition, they have been a Digital Mental Health & Neurology Advisory Board Member at HealthXL. Previously, Benjamin was the Chief Medical Officer at Limbix, where they developed digital therapeutics for adolescent mental health. Benjamin has also served as the Chief Medical Officer at Aetna Better Health Inc. and Aetna, a CVS Health Company, where they managed utilization review and prior authorization processes. Prior to that, Benjamin worked at OPTUM360 SERVICES, INC. as a Senior Physician Advisor and Retrospective Physician Advisor. Benjamin'sresponsibilities included medical necessity reviews, appeals letter writing, and the development of evidence-based clinical standards guidelines. Benjamin's work experience demonstrates their expertise in healthcare leadership, digital health, and medical advisory roles.

Benjamin A. earned a Bachelor of Arts (B.A.) degree in Psychology from Brandeis University in 1990. Benjamin then pursued a Doctor of Medicine (MD) degree from Albany Medical College, which they completed in 1994. Later, in 2015, they obtained a Master of Business Administration (MBA) degree with a focus on Health/Health Care Administration/Management from Widener University. Benjamin A. holds several additional certifications, including the American Board of Pediatrics certification in 1998 and medical licenses from the states of Delaware, Pennsylvania, and New Jersey in 2002, 2001, and 2021 respectively. Benjamin also obtained a certification from MIT xPRO in Drug and Medical Device Development: A Strategic Approach in 2024, through Emeritus institution.